Related Experiment Videos
Predictors of response to mood stabilizers
J R Calabrese1, S H Fatemi, M Kujawa
1Department of Psychiatry, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Ohio, USA.
Journal of Clinical Psychopharmacology
|April 1, 1996
Summary
Lithium is a common bipolar disorder treatment, but its effectiveness varies. Specific patient factors like mixed states may predict better responses to divalproex or carbamazepine over lithium.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Lithium is the primary treatment for bipolar disorder, yet response rates range from 50-80% across patient populations.
- Predictors of treatment response are crucial for optimizing patient outcomes in bipolar disorder management.
Purpose of the Study:
- To review clinical presentations that predict general and differential responses to mood stabilizers.
- To identify patient subgroups that may respond better to specific mood-stabilizing medications.
Main Methods:
- Literature review of clinical presentations and treatment response in bipolar disorder.
- Analysis of factors influencing differential response to lithium, divalproex, and carbamazepine.
Main Results:
- General predictors of mood stabilizer response include natural history, illness subtype, and comorbidity.
- Mixed states and rapid cycling appear to be key predictors favoring divalproex or carbamazepine over lithium.
Conclusions:
- Understanding clinical presentations is vital for predicting individual responses to mood stabilizers.
- Differential response patterns suggest personalized treatment strategies for bipolar disorder based on illness characteristics.